A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes
Platzbecker, U, Symeonidis, A, Oliva, E N, Goede, J S, Delforge, M, Mayer, J, Slama, B, Badre, S, Gasal, E, Mehta, B, Franklin, J
Published in Leukemia (01.09.2017)
Published in Leukemia (01.09.2017)
Get full text
Journal Article
A randomized, open-label, phase II open platform study evaluating the efficacy and safety of novel spartalizumab (PDR001) combinations in previously treated unresectable or metastatic melanoma (PLATForM)
Weber, J., Long, G.V., Haanen, J.B., Arance, A., Dummer, R., Nathan, P., Ribas, A., Ascierto, P.A., Robert, C., Gasal, E., D’Amelio, A., Bettinger, S., Boran, A.D., Schadendorf, D.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A Phase 3 Randomized Placebo (PBO)-Controlled Double-Blind Trial of Darbepoetin Alfa in Low or Intermediate-1 (INT-1) Risk Myelodysplastic Syndromes (MDS)
Platzbecker, U, Symeonidis, A, Oliva, E, Goede, J, Delforge, M, Mayer, J, Slama, B, Badre, S, Gasal, E, Mehta, B, Franklin, J
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
Robert, Caroline, Grob, Jean J, Stroyakovskiy, Daniil, Karaszewska, Boguslawa, Hauschild, Axel, Levchenko, Evgeny, Chiarion Sileni, Vanna, Schachter, Jacob, Garbe, Claus, Bondarenko, Igor, Gogas, Helen, Mandalá, Mario, Haanen, John B.A.G, Lebbé, Celeste, Mackiewicz, Andrzej, Rutkowski, Piotr, Nathan, Paul D, Ribas, Antoni, Davies, Michael A, Flaherty, Keith T, Burgess, Paul, Tan, Monique, Gasal, Eduard, Voi, Maurizio, Schadendorf, Dirk, Long, Georgina V
Published in The New England journal of medicine (15.08.2019)
Published in The New England journal of medicine (15.08.2019)
Get full text
Journal Article
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
Dummer, Reinhard, Hauschild, Axel, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Kirkwood, John M, Chiarion Sileni, Vanna, Larkin, James, Nyakas, Marta, Dutriaux, Caroline, Haydon, Andrew, Robert, Caroline, Mortier, Laurent, Schachter, Jacob, Lesimple, Thierry, Plummer, Ruth, Dasgupta, Kohinoor, Gasal, Eduard, Tan, Monique, Long, Georgina V, Schadendorf, Dirk
Published in The New England journal of medicine (17.09.2020)
Published in The New England journal of medicine (17.09.2020)
Get full text
Journal Article
1031P ANV419, a selective IL-2Rβ/γ agonist in patients with relapsed/refractory advanced solid tumors
Calvo, E., Joerger, M., Läubli, H., Lopez, J.S., Alonso, G., Corral de la Fuente, E., Hess, D., König, D., Perez, V., Gasal, E., Jethwa, S., Di Blasi, D., Garralda, E.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1337P - Analysis of pyrexia in patients (pts) treated with dabrafenib (D) and/or trametinib (T) across clinical trials
Robert, C., Schadendorf, D., Dummer, R., Flaherty, K.T., Tawbi, H.A., Menzies, A.M., D’Amelio, A., de Jong, E., Gasal, E., Long, G.V.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Analysis of pyrexia in patients (pts) treated with dabrafenib (D) and/or trametinib (T) across clinical trials
Robert, C., Schadendorf, D., Dummer, R., Flaherty, K.T., Tawbi, H.A., Menzies, A.M., D’Amelio, A., de Jong, E., Gasal, E., Long, G.V.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1337PAnalysis of pyrexia in patients (pts) treated with dabrafenib (D) and/or trametinib (T) across clinical trials
Robert, C, Schadendorf, D, Dummer, R, Flaherty, K T, Tawbi, H A, Menzies, A M, D’Amelio, A, de Jong, E, Gasal, E, Long, G V
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
561P Phase Ib study of ribociclib (R) + trametinib (T) in patients (pts) with metastatic/advanced solid tumours
LoRusso, P., Fakih, M., De Vos, F.Y.F.L., Beck, J.T., Merchan, J., Shapiro, G., Lin, C-C., Desai, J., Spratlin, J., Cascella, T., Sandalic, L., Abdelhady, A.M., Boran, A., Gasal, E., Janku, F., Van Cutsem, E.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
LBA43 Spartalizumab plus dabrafenib and trametinib (Sparta-DabTram) in patients (pts) with previously untreated BRAF V600–mutant unresectable or metastatic melanoma: Results from the randomized part 3 of the phase III COMBI-i trial
Nathan, P., Dummer, R., Long, G.V., Ascierto, P.A., Tawbi, H.A., Robert, C., Rutkowski, P., Leonov, O., Dutriaux, C., Mandala', M., Lorigan, P., Ferrucci, P.F., Flaherty, K.T., Brase, J.C., Green, S., Haas, T., Masood, A., Gasal, E., Ribas, A., Schadendorf, D.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Adverse event (AE) kinetics in patients (pts) treated with dabrafenib + trametinib (D + T) in the metastatic and adjuvant setting
Grob, J.J., Atkinson, V.G., Robert, C., Schadendorf, D., Nathan, P., Davies, M.A., Kefford, R., Dummer, R., Kirkwood, J.M., Flaherty, K.T., Ribas, A., Burgess, P., Gasal, E., Long, G.V., Hauschild, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1333P - Adverse event (AE) kinetics in patients (pts) treated with dabrafenib + trametinib (D + T) in the metastatic and adjuvant setting
Grob, J.J., Atkinson, V.G., Robert, C., Schadendorf, D., Nathan, P., Davies, M.A., Kefford, R., Dummer, R., Kirkwood, J.M., Flaherty, K.T., Ribas, A., Burgess, P., Gasal, E., Long, G.V., Hauschild, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1333PAdverse event (AE) kinetics in patients (pts) treated with dabrafenib + trametinib (D + T) in the metastatic and adjuvant setting
Grob, J J, Atkinson, V G, Robert, C, Schadendorf, D, Nathan, P, Davies, M A, Kefford, R, Dummer, R, Kirkwood, J M, Flaherty, K T, Ribas, A, Burgess, P, Gasal, E, Long, G V, Hauschild, A
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1304TiPA randomized, open-label, phase II open platform study evaluating the efficacy and safety of novel spartalizumab (PDR001) combinations in previously treated unresectable or metastatic melanoma (PLATForM)
Weber, J, Long, G V, Haanen, J B, Arance, A, Dummer, R, Nathan, P, Ribas, A, Ascierto, P A, Robert, C, Gasal, E, D'Amelio, A, Bettinger, S, Boran, A D, Schadendorf, D
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial
Wen, Patrick Y, Stein, Alexander, van den Bent, Martin, De Greve, Jacques, Wick, Antje, de Vos, Filip Y F L, von Bubnoff, Nikolas, van Linde, Myra E, Lai, Albert, Prager, Gerald W, Campone, Mario, Fasolo, Angelica, Lopez-Martin, Jose A, Kim, Tae Min, Mason, Warren P, Hofheinz, Ralf-Dieter, Blay, Jean-Yves, Cho, Daniel C, Gazzah, Anas, Pouessel, Damien, Yachnin, Jeffrey, Boran, Aislyn, Burgess, Paul, Ilankumaran, Palanichamy, Gasal, Eduard, Subbiah, Vivek
Published in The lancet oncology (01.01.2022)
Published in The lancet oncology (01.01.2022)
Get full text
Journal Article
Preliminary findings from part 1 of COMBI-i: A phase III study of anti–PD-1 antibody PDR001 combined with dabrafenib (D) and trametinib (T) in previously untreated patients (pts) with advanced BRAF V600-mutant melanoma
Dummer, Reinhard, Arance Fernández, Ana María, Hansson, Johan, Larkin, James M. G., Long, Georgina V., Gasal, Eduard, Kaper, Mathilde, Upalawanna, Allison, Mookerjee, Bijoyesh, Atkinson, Victoria
Published in JOURNAL OF CLINICAL ONCOLOGY (10.02.2018)
Published in JOURNAL OF CLINICAL ONCOLOGY (10.02.2018)
Get full text
Journal Article
Conference Proceeding
42 - A Phase 3 Randomized Placebo (PBO)-Controlled Double-Blind Trial of Darbepoetin Alfa in Low or Intermediate-1 (INT-1) Risk Myelodysplastic Syndromes (MDS)
Platzbecker, U., Symeonidis, A., Oliva, E., Goede, J., Delforge, M., Mayer, J., Slama, B., Badre, S., Gasal, E., Mehta, B., Franklin, J.
Published in Leukemia research (01.04.2017)
Published in Leukemia research (01.04.2017)
Get full text
Journal Article
A randomized, double-blind, placebo-controlled, phase III study comparing the combination of PDR001, dabrafenib and trametinib versus placebo, dabrafenib and trametinib in previously untreated patients with unresectable or metastatic BRAF V600-mutant melanoma (COMBI-i)
Gasal, E, Fernandez, AMA, Ascierto, PA, Atkinson, V, Dummer, R, Flaherty, KT, Grob, JJ, Hansson, J, Hassel, J, Larkin, J, Lebbe, C, Long, GV, Lorigan, P, Miller, W, Nathan, P, Ribas, A, Robert, C, Schadendorf, D, Tawbi, H, Upalawanna, A
Published in ANNALS OF ONCOLOGY (2017)
Get full text
Published in ANNALS OF ONCOLOGY (2017)
Conference Proceeding
Endovascular stentgrafting to improve the outcome of a highly morbid cohort of patients with combined thoracic and abdominal aortic pathologies
Mayer, D, Gasal, E, Pfammatter, T, Pfiffner, R, Turina, M, Lachat, M
Published in The Thoracic and Cardiovascular Surgeon (18.01.2005)
Published in The Thoracic and Cardiovascular Surgeon (18.01.2005)
Get full text
Conference Proceeding